Developmental programming: Impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females

Endocrinology

Volumn 151, Issue 2, 2010, Pages 595-605

  Padmanabhan, V ^a   Veiga Lopez, A ^a   Abbott, D H ^b   Recabarren, S E ^c   Herkimer, C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; TESTOSTERONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL PROGRAMMING; FEMALE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; INSULIN HOMEOSTASIS; INSULIN RESISTANCE; INSULIN SENSITIVITY; NONHUMAN; OBESITY; OVARY POLYCYSTIC DISEASE; OVERNUTRITION; PERINATAL DEVELOPMENT; PERINATAL PERIOD; PRENATAL PERIOD; PRIORITY JOURNAL; PROGENY; SHEEP; WEIGHT GAIN;

ANIMAL FEED; ANIMALS; DIHYDROTESTOSTERONE; FEMALE; OBESITY; OVERWEIGHT; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY, ANIMAL; SHEEP; TESTOSTERONE; WEIGHT GAIN;

EID: 74949096775     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-1015     Document Type: Article

References (66)

1. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774-800
2. Salley KE, Wickham EP, Cheang KI, Essah PA, Karjane NW, Nestler JE 2007 Glucose intolerance in polycystic ovary syndrome-a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 92:4546-4556
3. Lord JM, Flight IH, Norman RJ 2003 Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiroinositol) for polycystic ovary syndrome. Cochrane Database Syst Rev 3:CD003053
4. Essah PA, Nestler JE 2006 The metabolic syndrome in polycystic ovary syndrome. J Endocrinol Invest 29:270-280
5. Sam S, Dunaif A 2003 Polycystic ovary syndrome: syndrome XX? Trends Endocrinol Metab 14:365-370
6. Barber TM, McCarthy MI, Franks S, Wass JA 2007 Metabolic syndrome in polycystic ovary syndrome. Endokrynol Pol 58:34-41
7. Diamanti-Kandarakis E 2007 Role of obesity and adiposity in polycystic ovary syndrome. Int J Obes (Lond) 31(Suppl 2):S8 -S13; discussion S31-S32
8. Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ 4 December 2009 Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril 10.1016/j.fertnstert.2008.09.018
9. Boomsma CM, Fauser BC, Macklon NS 2008 Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med 26:72-84
10. MacPhee M 2008 Global childhood obesity: how to curb an epidemic. J Pediatr Nurs 23:1-4
11. Hart R, Norman R 2006 Polycystic ovarian syndrome-prognosis and outcomes. Best Pract Res Clin Obstet Gynaecol 2006 20:751-778
12. Stewart DR, Dombroski BA, Urbanek M, Ankener W, Ewens KG, Wood JR, Legro RS, Strauss 3rd JF, Dunaif A, Spielman RS 2006 Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity. J Clin Endocrinol Metab 91:4112-4117
13. Barker DJP 1994 Programming the baby. In: Mothers, babies, and disease in later life. London: BMJ Publishing Group; 14-36
14. Nijland MJ, Ford SP, Nathanielsz PW 2008 Prenatal origins of adult disease. Curr Opin Obstet Gynecol 20:132-138
15. Devaskar SU, Thamotharan M 2007 Metabolic programming in the pathogenesis of insulin resistance. Rev Endocr Metab Disord 8:105-113
16. Newbold RR, Padilla-Banks E, Snyder RJ, Jefferson WN 2007 Perinatal exposure to environmental estrogens and the development of obesity. Mol Nutr Food Res 51:912-917
17. Apter D 1998 Endocrine and metabolic abnormalities in adolescents with a PCOS-like condition: consequences for adult reproduction. Trends Endocrinol Metab 9:58-61
18. Davies MJ, Norman RJ 2002 Programming and reproductive functioning. Trends Endocrinol Metab 13:386-392
19. Dumesic DA, Abbott DH, Padmanabhan V 2007 Polycystic ovary syndrome and its developmental origins. Rev Endocr Metab Disord 8:127-141
20. Abbott DH, Dumesic DA, Eisner JR, Colman RJ, Kemnitz JW 1998 Insights into the development of polycystic ovary syndrome (PCOS) from studies of prenatally androgenized female rhesus monkeys. Trends Endocrinol Metab 9:62-67
21. Barnes RB, Rosenfield RL, Ehrmann DA, Cara JF, Cuttler L, Levitsky LL, Rosenthal IM 1994 Ovarian hyperandrogenism as a result of congenital adrenal virilizing disorders: evidence for prenatal masculanization of neuroendocrine function in women. J Clin Endocrinol Metab 79:1328-1333
22. Abbott DH, Dumesic DA, Levine JE, Dunaif A, Padmanabhan V 2006 Animal models and fetal programming of PCOS. In: Azziz R, Nestler JE, Dewailly D, eds. Contemporary endocrinology: androgen excess disorders inwomen:polycystic ovary syndrome and other disorders. 2nd ed. Totowa, New Jersey: Humana Press Inc.; 259-272
23. Beck-Peccoz P, Padmanabhan V, Baggiani AM, Cortelazzi D, Buscaglia M, Medri G, Marconi AM, Pardi G, Beitins IZ 1991 Maturation of hypothalamic-pituitary-gonadal function innormalhumanfetuses: circulating levels of gonadotropins, their common α-subunit and free testosterone, and discrepancy between immunological and biological activities of circulating follicle-stimulating hormone. J Clin Endocrinol Metab 73:525-532
24. Steckler TL, Herkimer C, Dumesic DA, Padmanabhan V 2009 Developmental programming: excess weight gain amplifies the effects of prenatal testosterone excess on reproductive cyclicity-implication to PCOS. Endocrinology 150:1456-1465
25. Zhou R, Bruns CM, Bird IM, Kemnitz JW, Goodfriend TL, Dumesic DA, Abbott DH 2007 Pioglitazone improves insulin action and normalizes menstrual cycles in a majority of prenatally androgenized female rhesus monkeys. Reprod Toxicol 23:438-448
26. Veiga-Lopez A, Herkimer C, Alekseyev A, Padmanabhan V, Developmental programming: rosiglitazone, an insulin sensitizer, improves insulin sensitivity and reproductive cycles in prenatal testosterone-treated female sheep. Program of the 90th Annual Meeting of The Endocrine Society, San Francisco, CA, 2008, p 51 (Abstract P2-495)
27. Eisner JR, Dumesic DA, Kemnitz JW, Abbott DH 2000 Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys. J Clin Endocrinol Metab 85:1206-1210
28. Recabarren SE, Padmanabhan V, Codner E, Lobos A, Durán C, Vidal M, Foster DL, Sir-Petermann T 2005 Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone.AmJ Physiol (Endocrinol Metab) 289: 801-806
29. Manikkam M, Crespi EJ, Doop DD, Herkimer C, Lee JS, Yu S, Brown MB, Foster DL, Padmanabhan V 2004 Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. Endocrinology 145:790-798
30. Steckler T, Manikkam M, Inskeep EK, Padmanabhan V 2007 Developmental programming: follicular persistence in prenatal testosterone-treated sheep is not programmed by androgenic actions of testosterone. Endocrinology 148:3532-3540
31. Veiga-Lopez A, Steckler TL, Abbott DH, Welch K, MohanKumar PS, Padmanabhan V 2009 Developmental programming: impact of prenatal testosterone excess on maternal and fetal steroid milieu. Biol Reprod 81:84
32. Huopio H, Jääskeläinen J, Komulainen J, Miettinen R, Kärkkäinen P, Laakso M, Tapanainen P, Voutilainen R, Otonkoski T 2002 Acute insulin response tests for the differential diagnosis of congenital hyperinsulinism. J Clin Endocrinol Metab 87:4502-4507
33. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470
34. Kaneko JJ 1989 Carbohydrate metabolism and its diseases. In: Kaneko JJ, ed. Clinical biochemistry of domestic animals. 4th ed. San Diego: Academic Press; 65-68
35. Wood RI, Foster DL 1998 Sexual differentiation of reproductive neuroendocrine function in sheep. Rev Reprod 3:130-140
36. Ballard PL 2005 Hormonal influences on fetal development. In: Taeusch HW, Ballard RA, Gleason CA, Avery ME, eds. Avery's diseases of the newborn. 8th ed. Philadelphia: Elsevier Saunders; 46-56
37. Goran MI, Gower BA 2001 Longitudinal studies on pubertal insulin resistance. Diabetes 50:2444-2450
38. Lin HY, Xu Q, Yeh S, Wang RS, Sparks JD, Chang C 2005 Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor. Diabetes 54:1717-1725
39. Alexanderson C, Eriksson E, Stener-Victorin E, Lystig T, Gabrielsson B, Lönn M, Holmäng A 2007 Postnatal testosterone exposure results in insulin resistance, enlarged mesenteric adipocytes, and an atherogenic lipid profile in adult female rats: comparisons with estradiol and dihydrotestosterone. Endocrinology 148:5369-5376
40. Handa RJ, Pak TR, Kudwa AE, Lund TD, Hinds L 2008 An alternate pathway for androgen regulation of brain function: activation of estrogen receptor β by the metabolite of dihydrotestosterone, 5α-androstane- 3β, 17 β-diol. Horm Behav 53:741-752
41. Bryzgalova G, Gao H, Ahren B, Zierath JR, Galuska D, Steiler TL, Dahlman-Wright K, Nilsson S, Gustafsson JA, Efendic S, Khan A 2006 Evidence that oestrogen receptor α plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 49:588-597
42. Veiga-Lopez A, Padmanabhan V, Developmental programming: opposing effects of prenatal testosterone and estradiol excess on insulin sensitivity and reproductive cyclicity in sheep and modulation by postnatal estradiol. Program of the 91st Annual Meeting of The Endocrine Society, Washington, DC, 2009 (Abstract P1-276)
43. Abbott DH, Goodfriend TL, Dunaif A, Muller SJ, Dumesic DA, Increased body weight and enhanced insulin sensitivity in infant female rhesus monkeys exposed to androgen excess during early gestation. Program of the 89th Annual Meeting of The Endocrine Society, Toronto, Canada, 2007, p 417 (Abstract P2-348)
44. Bergman RN 1989 Lilly lecture 1989: toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 38:1512-1527
45. Dumesic DA, Schramm RD, Abbott DH 2005 Early origins of polycystic ovary syndrome. Reprod Fertil Dev 17:349-360
46. Gatford KL, De Blasio MJ, Thavaneswaran P, Robinson JS, McMillen IC, Owens JA 2004 Postnatal ontogeny of glucose homeostasis and insulin action in sheep. Am J Physiol Endocrinol Metab 286:E1050-E1059
47. Demissie M, Lazic M, Foecking EM, Aird F, Dunaif A, Levine JE 2008 Transient prenatal androgen exposure produces metabolic syndrome in adult female rats.AmJ Physiol Endocrinol Metab 295: E262-E268
48. McDowell GH 1983 Hormonal control of glucose homoeostasis in ruminants. Proc Nutr Soc 42:149-167
49. Smith P, Steckler TL, Veiga-Lopez A, Padmanabhan V 2009 Developmental programming: differential effects of prenatal testosterone and dihydrotestosterone on follicular recruitment and depletion of follicular reserve. Biol Reprod 80:726-736
50. Foster DL, Jackson LM, Padmanabhan V 2006 Programming of GnRH feedback controls timing puberty and adult reproductive activity. Mol Cell Endocrinol 254-255:109-119
51. Plagemann A 2008 A matter of insulin: developmental programming of body weight regulation. J Matern Fetal Neonatal Med 21: 143-148
52. Bergman RN, Kim SP, Hsu IR, Catalano KJ, Chiu JD, Kabir M, Richey JM, Ader M 2007 Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. Am J Med 120(2 Suppl 1):S3-S8; discussion S29-S532
53. Matsuzawa Y 2008 The role of fat topology in the risk of disease. Int J Obes (Lond) 32(Suppl 7):S83-S92
54. Phillips LK, Prins JB 2008 The link between abdominal obesity and the metabolic syndrome. Curr Hypertens Rep 10:156-164
55. Bergman EN, Reulein SS, Corlett RE 1989 Effects of obesity on insulin sensitivity and responsiveness in sheep. Am J Physiol 257: E772-E781
56. Rossell R, Gomis R, Casamitjana R, Segura R, Vilardell E, Rivera F 1983 Reduced hepatic insulin extraction in obesity: relation with plasma insulin levels. J Clin Endocrinol Metab 56:608-611
57. Polonsky KS, Given BD, Hirsch L, Shapiro ET, Tillil H, Beebe C, Galloway JA, Frank BH, Karrison T, Van Cauter E 1988 Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 81:435-441
58. Ciampelli M, Fulghesu AM, Cucinelli F, Pavone V, Caruso A, Mancuso S, Lanzone A 1997 Heterogeneity in β cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome. Hum Reprod 12:1897-1901
59. McGarry JD 2002 Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51:7-18
60. Kusminski CM, Shetty S, Orci L, Unger RH, Scherer PE 2009 Diabetes and apoptosis: lipotoxicity. Apoptosis 14:1484-1495
61. Mühlhausler BS 2009 Nutritional models of type 2 diabetes mellitus. Methods Mol Biol 560:19-36
62. Mingrone G, Manco M, Mora ME, Guidone C, Iaconelli A, Gniuli D, Leccesi L, Chiellini C, Ghirlanda G 2008 Influence of maternal obesity on insulin sensitivity and secretion in offspring. Diabetes Care 31:1872-1876
63. Sir-Petermann T, Codner E, Pérez V, Echiburú B, Maliqueo M, Ladrón de Guevara AL, Preisler J, Crisosto N, Sánchez F, Cassorla F, Bhasin S 2009 Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 94:1923-1930
64. Hofman PL, Cutfield WS 2006 Insulin sensitivity in people born preterm, with low or very low birth weight and small for gestational age. J Endocrinol Invest 29(Suppl 1):2-8
65. Boney CM, Verma A, Tucker R, Vohr BR 2005 Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 115:e290-e296
66. Dulloo AG 2008 Thrifty energy metabolism in catch-up growth trajectories to insulin and leptin resistance. Best Pract Res Clin Endocrinol Metab 22:155-171